Conavi Medical Corp (CNVI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 186 | 200 | 203 | 202 | 208 |
| Accounts receivable | -34 | -14 | -88 | 531 | 265 |
| Other Working Capital | 630 | -644 | -3,542 | 1,710 | -1,186 |
| Other Operating Activity | -5,022 | -4,521 | -4,329 | -6,090 | -8,005 |
| Operating Cash Flow | $-4,240 | $-4,979 | $-7,756 | $-3,647 | $-8,718 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -30 | -11 | -6 | -27 | -29 |
| Purchase Sale Intangibles | -115 | -89 | 0 | -7 | -14 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 3,753 |
| Investing Cash Flow | $-145 | $-100 | $-6 | $-34 | $3,710 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -485 | -301 | -428 | -373 | -430 |
| Common Stock Issued | 0 | -40 | 12,112 | 0 | 10,092 |
| Other Financing Activity | 0 | -22 | 6,325 | 0 | 0 |
| Financing Cash Flow | $-485 | $-363 | $18,009 | $-373 | $9,662 |
| Beginning Cash Position | 5,841 | 11,283 | 1,036 | 5,090 | 436 |
| End Cash Position | 971 | 5,841 | 11,283 | 1,036 | 5,090 |
| Net Cash Flow | $-4,870 | $-5,442 | $10,247 | $-4,054 | $4,654 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,240 | -4,979 | -7,756 | -3,647 | -8,718 |
| Capital Expenditure | -145 | -100 | -6 | -34 | -43 |
| Free Cash Flow | -4,385 | -5,079 | -7,762 | -3,681 | -8,761 |